Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas
Clinical trial NCT00785798 · TERMINATED
Trial details
- NCT number
- NCT00785798
- Sponsor
- Yale University
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2011-09-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.